Clinical Trial Update: Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib [Phase 2]

View source ↗

Summary

Phase 2 study evaluating high-dose carfilzomib in multiple myeloma patients who progressed on standard-dose carfilzomib; the trial is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Ajai Chari | Conditions: Relapse Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-21